- Home
- CGBD vs EIKN Comparison
CGBD vs EIKN Comparison
Compare CGBD & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | EIKN |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | 2500 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 785.1M | 631.0M |
| IPO Year | 2013 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CGBD | EIKN |
|---|---|---|
| Price | $11.22 | $8.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $12.92 | ★ $25.60 |
| AVG Volume (30 Days) | 408.4K | ★ 491.2K |
| Earning Date | 05-11-2026 | 03-30-2026 |
| Dividend Yield | ★ 14.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $1.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.95 | $7.90 |
| 52 Week High | $13.28 | $16.50 |
Technical Indicators
Market Signals| Indicator | CGBD | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.